DNA methylation detection using MS-qFRET, a quantum dot-based nanoassay (Q37723600)

22 August 2017

1 reference

title

DNA methylation detection using MS-qFRET, a quantum dot-based nanoassay (English)

1 reference

22 August 2017

0 references

0 references

Vasudev J Bailey

1

1 reference

22 August 2017

Brian P Keeley

2

1 reference

22 August 2017

Christopher R Razavi

3

1 reference

22 August 2017

Elizabeth Griffiths

4

1 reference

22 August 2017

Hetty E Carraway

5

1 reference

22 August 2017

Tza-Huei Wang

6

1 reference

22 August 2017

publication date

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

52

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

237-241

1 reference

DNA methylation patterns and epigenetic memory

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

The power and the promise of DNA methylation markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Gene silencing in cancer in association with promoter hypermethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

DNA methylation markers and early recurrence in stage I lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Cancer epigenetics comes of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

MethyLight: a high-throughput assay to measure DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

MS-qFRET: a quantum dot-based method for analysis of DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Single-quantum-dot-based DNA nanosensor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Cancer epigenetics and methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

DNA methylation and gene silencing in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Myelodysplastic syndromes (MDSs) and acute myelogenous leukemia (AML) comprise a closely linked continuum of malignant hematologic diseases. Introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

DNA methyltransferase inhibitors for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

DNA methyltransferase inhibitors and the development of epigenetic cancer therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Future directions in myelodysplastic syndrome: newer agents and the role of combination approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Azacytidine causes complex DNA methylation responses in myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Cellular differentiation, cytidine analogs and DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Self-assembled nanoscale biosensors based on quantum dot FRET donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

Enzymatic incorporation of multiple dyes for increased sensitivity in QD-FRET sensing for DNA methylation detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.03.007

10.1016/J.YMETH.2010.03.007

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference